By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Advanced Wound Closure’s New Players
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Advanced Wound Closure’s New Players
Medical DevicesMedical InnovationsSpecialtiesTechnology

Advanced Wound Closure’s New Players

PatrickDriscoll
PatrickDriscoll
Share
3 Min Read
sealants-global-market
SHARE

The global market for products in “wound securement,” or the aggregate of products that are related to the closure and healing of wounds, is dominated by traditional products — sutures and the more recent clips and staples. However, as simple and effective as these are, particularly since their use is engrained in the skillsets of practicing surgeons, advances in wound closure, hemostasis and even anti-adhesion are challenging the entrenched positions of suture, staple and clip suppliers.  

The global market for products in “wound securement,” or the aggregate of products that are related to the closure and healing of wounds, is dominated by traditional products — sutures and the more recent clips and staples. However, as simple and effective as these are, particularly since their use is engrained in the skillsets of practicing surgeons, advances in wound closure, hemostasis and even anti-adhesion are challenging the entrenched positions of suture, staple and clip suppliers.  

Fibrin and other sealants have found acceptance in use by surgeons seeking tighter wound sealing, faster healing, less scarring and other benefits.  Hemostatic agents have proven highly versatile (in a range of clinical settings from the OR to the battlefield) in rapidly stopping bleeds in a way that traditional wound closure cannot. The end result of surgery also demands that the surgery itself cause a minimum of complications, and products in anti-adhesion (many actually being sealant products that are actually effective in what one might consider the “opposite” role) have proved effective in this capacity.

But old habits die hard, so very high caseload of wound closure is still addressed via sutures, staples and clips.  Consequently, the global market for wound closure and related products has companies like Ethicon (J&J) holding big pieces of the pies.

More Read

Screen Shot 2014-04-08 at 9.26.25 AM
Growth in Sales of Products in Cell Therapy and Tissue Engineering
Screening for Alzheimer’s Disease: Some Progress
What You Need to Know About This Year’s AdvaMed Conference
HIPAA Challenges
Insomnia: Fears and Treatment – Part II

sealants-global-market

Legend:

A: Ethicon/J&J
B: Covidien
C: B. Braun
D: Others
E: 3M
F: CSL Behring
G: Pfizer
H: Equimedical BV
I: Baxter
J: Cryolife
K: AdMedSol
L: Genzyme Biosurgery

Source: “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2012-2017″, MedMarket Diligence Report #S190.

TAGGED:emergency medicinewound closurewound technology
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

doctor patient relationship
BusinesseHealthMedical RecordsTechnology

We’ll Have to Get to Know Patients Better

February 18, 2015
Technology

The Age Of Technology: What Healthcare Can Learn From Fintech

December 14, 2018

EHR Interoperability: Let’s Stop Beating a Dead Drum

April 29, 2015
RSNA 2015
Medical Devices

RSNA 2015: Important Presentations and Studies from Day 4

December 4, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?